As of Feb 05
| -0.68 / -3.31%|
The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 31.00, with a high estimate of 50.00 and a low estimate of 23.00. The median estimate represents a +56.01% increase from the last price of 19.87.
The current consensus among 8 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.